Jin Medical International Ltd. - ZJYL

ZJYL Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
ZJYL	6.6	-25.5	-41.6	-59.8	-57.1	220.2	267.3	267.3	267.3	267.3
S&P 500	-0.7	-1.1	1.6	6.6	11.3	31.3	26.2	89.4	189.5	33366.3

Compare ZJYL with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	ZJYL
name	Jin Medical International Ltd.
price	1.45
changes percentage	5.50
change	0.08
day low	1.45
day high	1.46
year high	25.49
year low	0.55
market cap	226273178
price avg 50	2.38
price avg 200	3.76
exchange	NASDAQ
volume	19968
avg volume	295100
open	1.46
previous close	1.37
eps	0.02
pe	72.27
earnings announcement	None
shares outstanding	156547100
timestamp	2024-11-15 14:33:14

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 77.0%

Overall Quarterly Financial Health: 11.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001837821
revenue	19821457	19190541	3.29
gross profit	6784834	6198518	9.46
gross profit ratio	0.34	0.32	5.97
research and development expenses	1542894	1892532	-18.47
operating expenses	3917572	4067994	-3.70
interest income	0	181605	-100.00
interest expense	0	0	NaN
ebitda	3442885	3099908	11.06
ebitdaratio	0.17	0.12	44.50
operating income	2867262	2130524	34.58
operating income ratio	0.14	0.11	30.30
net income	2878230	2706527	6.34
net income ratio	0.15	0.14	2.96
eps	0.02	0.34	-94.18

Overall Score of Annual Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 20 million in 2023 from 19 million in 2022 representing a change of 3.29%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 7 million in 2023 from 6 million in 2022 representing a change of 9.46%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 4 million in 2023 from 4 million in 2022 representing a change of -3.7%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 3 million in 2023 from 3 million in 2022 representing a change of 11.06%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 3 million in 2023 from 2 million in 2022 representing a change of 34.58%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 3 million in 2023 from 3 million in 2022 representing a change of 6.34%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 2 million in 2023 from 2 million in 2022 representing a change of -18.47%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Earnings per Share (EPS): EPS increased to 0.02 in 2023 from 0.02 in 2022 representing a change of -94.18%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0001837821
revenue	5278446	5278446	0.00
gross profit	1898653	1898653	0.00
gross profit ratio	0.36	0.36	0.00
research and development expenses	304823	304823	0.00
operating expenses	1284034	1232745	4.16
interest income	681588	340794	100.00
interest expense	0	0	NaN
ebitda	674642	674642	0.00
ebitdaratio	0.13	0.13	0.00
operating income	614619	614619	0.00
operating income ratio	0.12	0.12	0.00
net income	897047	897047	0.00
net income ratio	0.17	0.17	0.00
eps	0.01	0.01	0.00

Overall Score of Quarterly Income Statement

0.0 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 1 million in 2024Q2 from 1 million in 2024Q1 representing a change of 4.16%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001837821
total assets	32903450	20939534	57.14
total liabilities	8924345	5703843	56.46
total equity	23979105	15235691	57.39
cash and cash equivalents	6929508	4792632	44.59
short term investments	9768835	2276158	329.18
long term investments	0	-864609	100.00
total current assets	31115815	18903147	64.61
total non current assets	1787635	2036387	-12.22
total current liabilities	8924345	5703843	56.46
total non current liabilities	0	0	NaN
common stock	7797	6750	15.51
retained earnings	16927605	14408843	17.48
total debt	4113000	0	NaN

Overall Score of Annual Balance Sheet

0.7 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 33 million in 2023 from 21 million in 2022 representing a change of 57.14%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 24 million in 2023 from 15 million in 2022 representing a change of 57.39%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 7 million in 2023 from 5 million in 2022 representing a change of 44.59%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 10 million in 2023 from 2 million in 2022 representing a change of 329.18%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 31 million in 2023 from 19 million in 2022 representing a change of 64.61%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 0 in 2023 from 0 in 2022 representing a change of 15.51%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 17 million in 2023 from 14 million in 2022 representing a change of 17.48%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 9 million in 2023 from 6 million in 2022 representing a change of 56.46%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 9 million in 2023 from 6 million in 2022 representing a change of 56.46%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 4 million in 2023 from 0 million in 2022 representing a change of nan%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0001837821
total assets	41160123	41160123	0.00
total liabilities	15005210	15005210	0.00
total equity	26154913	26154913	0.00
cash and cash equivalents	8874902	8874902	0.00
short term investments	17113103	17113103	0.00
long term investments	0	0	NaN
total current assets	38177840	38177840	0.00
total non current assets	2982283	2982283	0.00
total current liabilities	14825519	14825519	0.00
total non current liabilities	179691	179691	0.00
common stock	7827.0	7827.0	0.00
retained earnings	20732589	20732589	0.00
total debt	9949138	9860841	0.90

Overall Score of Quarterly Balance Sheet

0.0 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Debt: Total Debt increased to 10 million in 2024Q2 from 10 million in 2024Q1 representing a change of 0.9%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001837821
net change in cash	2136876	1120372	90.73
operating cash flow	3106403	1580656	96.53
free cash flow	2992466	1540490	94.25
capital expenditure	-113937	-40166	-183.67
depreciation and amortization	225902	362597	-37.70
deferred income tax	89603	-86023	204.16
stock based compensation	0	0	NaN
accounts payables	-646886	-810342	20.17
inventory	1555441	-504387	408.38
acquisitions net	0	0	NaN
investments in property plant and equipment	-113937	-40166	-183.67
net cash used for investing activites	-7730248	-120904	-6,293.71
debt repayment	4254000	0	NaN
common stock issued	8000000	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	6910619	121855	5,571.18
cash at end of period	6929508	4792632	44.59
accounts receivables	-376079	333657	-212.71
cash at beginning of period	4792632	3672260	30.51

Overall Score of Annual Cashflow Statement

0.86 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 2 million in 2023 from 1 million in 2022 representing a change of 90.73%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 3 million in 2023 from 2 million in 2022 representing a change of 96.53%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 3 million in 2023 from 2 million in 2022 representing a change of 94.25%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to 0 million in 2023 from 0 million in 2022 representing a change of -183.67%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 1 million in 2023 from 1 million in 2022 representing a change of 20.17%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to 0 million in 2023 from 0 million in 2022 representing a change of -212.71%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Deferred Income Tax: Deferred Income Tax increased to 0 million in 2023 from 0 million in 2022 representing a change of 204.16%. This indicates that the company's tax liability for future periods has increased.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0001837821
operating cash flow	24999	24999	0.00
free cash flow	-16841	-16841	0.00
capital expenditure	-41840	-41840	0.00
depreciation and amortization	84076	84076	0.00
deferred income tax	23711	0	NaN
stock based compensation	0	0	NaN
accounts receivables	-512322	-512322	0.00
accounts payables	-278216	0	NaN
inventory	283367	283367	0.00
acquisitions net	348.0	0	NaN
investments in property plant and equipment	-41840	-41840	0.00
net cash used for investing activites	-2074619	-2074619	0.00
debt repayment	0	0	NaN
common stock issued	311995	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	3002149	3002149	0.00
net change in cash	1945394	972698	100.00
cash at end of period	8874902	972698	812.40
cash at beginning of period	6929508	0	NaN

Overall Score of Quarterly Cashflow Statement

0.33 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 2 million in 2024Q2 from 1 million in 2024Q1 representing a change of 100.0%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

• 📉 Negative Indicators

  Deferred Income Tax: Deferred Income Tax increased to 0 million in 2024Q2 from 0 million in 2024Q1 representing a change of nan%. This indicates that the company's tax liability for future periods has increased.

  Accounts Payables: The absolute value of Accounts Payables increased to 0 million in 2024Q2 from 0 million in 2024Q1 representing a change of nan%. This indicates that the company has increased its outstanding obligations to its suppliers.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-09-30	2022-09-30	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	0.14	2.4	-94.31
net income per share	0.02	0.34	-94.14
operating cash flow per share	0.02	0.2	-89.17
free cash flow per share	0.02	0.19	-89.29
cash per share	0.12	0.88	-86.98
book value per share	0.17	1.9	-91.32
tangible book value per share	0.16	1.88	-91.29
shareholders equity per share	0.17	1.9	-91.32
interest debt per share	0.03	0	NaN
market cap	169811360.55	3180000	5,239.98
enterprise value	166994852.55	-1612632	10,455.42
pe ratio	59.0	1.17	4,921.42
price to sales ratio	8.57	0.17	5,070.01
pocfratio	54.66	2.01	2,617.18
pfcf ratio	56.75	2.06	2,648.97
pb ratio	7.08	0.21	3,292.88
ptb ratio	7.08	0.21	3,292.88
ev to sales	8.42	-0.08	10,125.81
enterprise value over ebitda	48.5	-0.52	9,423.82
ev to operating cash flow	53.76	-1.02	5,369.23
ev to free cash flow	55.81	-1.05	5,430.86
earnings yield	0.02	0.85	-98.01
free cash flow yield	0.02	0.48	-96.36
debt to equity	0.17	0	NaN
debt to assets	0.13	0	NaN
net debt to ebitda	-0.82	-1.55	47.09
current ratio	3.49	3.31	5.21
interest coverage	0	0	NaN
income quality	1.08	0.58	84.80
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.1	0.09	4.89
research and ddevelopement to revenue	0.08	0.1	-21.07
intangibles to total assets	0.0	0.01	-39.81
capex to operating cash flow	0.04	0.03	44.34
capex to revenue	0.01	0.0	174.64
capex to depreciation	0.5	0.11	355.31
stock based compensation to revenue	0	0	NaN
graham number	0.27	3.81	-92.87
roic	0.09	0.14	-33.93
return on tangible assets	0.09	0.13	-32.53
graham net net	0.11	0.99	-88.39
working capital	22191470	13199304	68.13
tangible asset value	23824741	15072478	58.07
net current asset value	22191470	13199304	68.13
invested capital	23826630	14990479	58.95
average receivables	6376323	5115820.5	24.64
average payables	3752350.5	4732363.5	-20.71
average inventory	5888775.5	6808592.5	-13.51
days sales outstanding	156.53	80.87	93.55
days payables outstanding	94.94	115.57	-17.85
days of inventory on hand	141.48	188.92	-25.11
receivables turnover	2.33	4.51	-48.33
payables turnover	3.84	3.16	21.72
inventory turnover	2.58	1.93	33.53
roe	0.12	0.18	-32.43
capex per share	0.0	0.01	-84.36

• ROE:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 59.00 on 2023-09-30 from 1.17 on 2022-09-30, representing a change of 4921.42%. Indicating an increase in the relative valuation of the company's stock.

• Negative

  Current Ratio: Current Ratio increased to 3.49 on 2023-09-30 from 3.31 on 2022-09-30, representing a change of 5.21%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Quarterly Financial Ratios

	2024-03-31 Q2	2023-12-31 Q1	Q/Q change %
ZJYL
calendar year	2024	2024	NaN
revenue per share	0.03	0.03	0.00
net income per share	0.01	0.01	0.00
operating cash flow per share	0.0	0.0	0.00
free cash flow per share	-0.0	-0.0	0.00
cash per share	0.17	0.17	0.00
book value per share	0.17	0.17	0.00
tangible book value per share	0.16	0.16	0.00
shareholders equity per share	0.17	0.17	0.00
interest debt per share	0.06	0.06	0.00
market cap	522430161.44	1994306754	-73.80
enterprise value	523504397.44	1995292693	-73.76
pe ratio	145.6	555.8	-73.80
price to sales ratio	98.97	377.82	-73.80
pocfratio	20898.04	79775.46	-73.80
pfcf ratio	-31021.33	-118419.73	73.80
pb ratio	19.91	75.99	-73.80
ptb ratio	19.91	75.99	-73.80
ev to sales	99.18	378.01	-73.76
enterprise value over ebitda	775.97	2957.56	-73.76
ev to operating cash flow	20941.01	79814.9	-73.76
ev to free cash flow	-31085.11	-118478.28	73.76
earnings yield	0.0	0.0	281.74
free cash flow yield	-0.0	-0.0	-281.74
debt to equity	0.37	0.37	0.00
debt to assets	0.24	0.24	0.00
net debt to ebitda	1.59	1.46	8.96
current ratio	2.58	2.58	0.00
interest coverage	0	0	NaN
income quality	0.03	0.03	0.00
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.15	0.15	0.00
research and ddevelopement to revenue	0.06	0.06	0.00
intangibles to total assets	0.03	0.03	0.00
capex to operating cash flow	1.67	1.67	0.00
capex to revenue	0.01	0.01	0.00
capex to depreciation	0.5	0.5	0.00
stock based compensation to revenue	0	0	NaN
graham number	0.15	0.15	0.00
roic	0.01	0.01	0.00
return on tangible assets	0.02	0.02	0.00
graham net net	0.12	0.12	0.00
working capital	23352321	23352321	0.00
tangible asset value	25030509	25030509	0.00
net current asset value	23172630	23172630	0.00
invested capital	26204163	26204163	0.00
average receivables	5381099	6940845	-22.47
average payables	3146451	3268765	-3.74
average inventory	6368089	5710612.5	11.51
days sales outstanding	91.75	91.75	0.00
days payables outstanding	83.79	83.79	0.00
days of inventory on hand	169.57	169.57	0.00
receivables turnover	0.98	0.98	0.00
payables turnover	1.07	1.07	0.00
inventory turnover	0.53	0.53	0.00
roe	0.03	0.03	0.00
capex per share	0.0	0.0	0.00

• Negative

  ROE: Return on Equity (ROE) decreased to 0.03 on 2024-03-31 Q2 from 0.03 on 2023-12-31 Q1, representing a change of 0.00%. Suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 145.60 on 2024-03-31 Q2 from 555.80 on 2023-12-31 Q1, representing a change of -73.80%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 2.58 on 2024-03-31 Q2 from 2.58 on 2023-12-31 Q1, representing a change of 0.00%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.37 on 2024-03-31 Q2 from 0.37 on 2023-12-31 Q1, representing a change of 0.00%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 0.04 which is lower than current price 1.45, indicates the company may be overvalued.